Mechanistically, UBE2T inhibition in breast cancer cells suppresses interferon alpha–inducible protein 6 (IFI6) expression, resulting in DNA replication stress, cell cycle arrest, and apoptosis induction. Here, IFI6 is linked to breast carcinoma.